The UCSF Interstitial Lung Disease (ILD) Program is dedicated to improving the lives of patients with interstitial lung disease, or ILD. We do this by focusing on patient care, education and research, and community building.
The program specializes in the comprehensive care of people with all types of ILD. We provide state-of-the-art diagnosis and treatment recommendations, working as a team to review each case thoroughly so as to optimize disease and symptom management. We communicate directly with patients and their referring doctors to assure continuity of care and appropriate follow-up.
As part of an academic medical center, we are committed to meeting the educational needs of our community. For patients and families, we hold seminars on ILD and offer a support group for anyone affected by this condition, called Living Well With ILD. For doctors and other health care providers, we offer continuing medical education sessions on interstitial lung disease as well as a quarterly newsletter.
Cyclophosphamide is part of a class of drugs called immunosuppressants that suppress the immune response and reduces inflammation in the lungs. Learn more.
Commonly asked questions regarding Methotrexate including, recommendation, precautions, possible side effects, suggested monitoring and more.
Commonly asked questions regarding Mycophenolate including recommendation, precautions, possible side effects, suggested monitoring and more.
Commonly asked questions regarding Prednisone including, the reason for recommendation, special precautions, possible side effects, monitoring, and more.
GERD in ILD Patients
Many studies have shown a link between GERD & lung disease, including interstitial lung disease (ILD). The reason for this relationship is unclear. Learn more.
ILD Nutrition Manual
Nutrition Manual for Interstitial Lung Disease including, General Guidelines for Eating Healthy, Body Mass Index, Increasing Protein in Your Diet and more.
Patients living with interstitial lung disease (ILD) will find numerous resources listed here, offering information and support.
Pulmonary Hypertension and Interstitial Lung Disease
Pulmonary hypertension, or PH, occurs when blood pressure in the lungs becomes elevated, and can be caused by a thickening of the pulmonary artery walls.
Pulmonary Rehabilitation for ILD Patients
Pulmonary rehabilitation is a comprehensive program for lung disease patients whose symptoms are impacting their everyday activities. Learn more here.
Find Supplemental Oxygen Resources including, The Need for Supplemental Oxygen, Your Oxygen Equipment, Oxygen Safety, Traveling With Oxygen, and more.
Harold R. Collard Jr.
Talmadge E. King Jr.
Paul J. Wolters
Brett M. Elicker
MD, MPHHeart and lung surgeon
Epigenetic Regulation of Altered T-cell Immunity in Sarcoidosis
Sarcoidosis is a multi-system granulomatous disorder that is triggered and influenced by gene-environment interactions. Although sarcoidosis predominantly affects the lungs in most cases, the clinical disease course ...
Study of Pulmonary Rehabilitation in Patients With Idiopathic Pulmonary Fibrosis (IPF)
The main objectives of this study are: - Determine the difference in change from baseline in Six Minute Walk Distance (6MWD) when pulmonary rehabilitation (PR) is added to stable underlying nintedanib thera...
Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate
A Phase II multi-center, double-blind, parallel group, randomized and placebo-controlled clinical trial addressing the treatment of patients with active and symptomatic Scleroderma-related interstitial lung disease (...
JUNIPER: A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in...
A phase 2, randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety, tolerability, biological activity, and pharmacokinetics (PK) of ND-L02-s0201 for Injection in subjects with IPF.
Pirfenidone for Restrictive Chronic Lung Allograft Dysfunction
Despite advances in lung transplantation, the median survival remains only 55% at 5 years. The main limitation to long term survival is the development of chronic lung allograft dysfunction. In approximately 30% of c...
Awards & recognition
Best in Northern California for pulmonology and lung surgery
Ranked No. 8 in the nation for pulmonology and lung surgery
Designated pulmonary fibrosis care center
new patients treated each year
Case Management and Social Work
Connect with a team that can help you find resources, solve problems and advocate for you during treatment at UCSF.
Mindfulness-Based Stress Reduction Class
This eight-week UCSF class teaches mindfulness practices, such as meditation and body awareness, that can reduce stress and improve your overall health.
We welcome feedback about your experience at UCSF Health. Find out how to contact us with comments, questions or concerns.
Pulmonary Support Groups
The UCSF AWAKE ("Alert, Well And Keeping Energetic") Obstructive Sleep Apnea Support Group is for people with this sleep and breathing disorder.
Spiritual Care Services
Chaplains representing many faiths are available around the clock to provide support, comfort and counsel to patients, families and caregivers. Learn more.
Plan your visit
If you live in another country and are coming to UCSF for medical
treatment, our patient liaisons can help coordinate all aspects of your visit.
UCSF offers language services at no charge for patients with limited
English, as well as for patients who are deaf or have trouble hearing.
Checking into the hospital? Find helpful information by clicking on the relevant “Your Hospital Stay” booklet: Mission Bay, Parnassus or Mount
Your Doctor Visit
See our top 10 tips for making your UCSF doctor’s appointment as stress-free and productive as possible.
What to Bring
- Photo I.D.
- Health insurance card
- Insurance authorization, if required
- Doctor's referral, if required
- Recent test results related to your condition
- List of your medications, including dosages, plus any you're allergic to
- List of questions you may have
- Device or paper for taking notes
Lung Transplant Program
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143
Our research initiatives
Interstitial Lung Disease Research
UCSF's interstitial lung disease researchers investigate how lung tissue scarring develops and progresses, and evaluate potential new treatments.